UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Aromatic amino acid metabolism during liver failure

Dejong, CHC; van de Poll, MCG; Soeters, PB; Jalan, R; Damink, SWMO; (2007) Aromatic amino acid metabolism during liver failure. JOURNAL OF NUTRITION , 137 (6) 1579S - 1585S.

Full text not available from this repository.

Abstract

Liver failure is associated with hepatic encephalopathy (HE). An imbalance in plasma levels of aromatic amino acids (AAA) phenylalanine, tyrosine, and tryptophan and branched chain amino acids (BCAA) and their BCAA/AAA ratio has been suggested to play a causal role in HE,by enhanced brain AAA uptake and subsequently disturbed neurotransmission. Until recently, data on this subject and the role of the liver and splanchnic bed were scarce, particularly in humans, due to inaccessibility of portal and hepatic veins. Here, we discuss, against a background of relevant literature, data obtained in patients undergoing liver resection or with a transjugular intrahepatic portasystemic stent shunt (TIPSS), where these veins are accessible. The BCAA/AAA ratio remained unchanged after major liver resection, but plasma AAA levels were inversely correlated (P < 0.001) with residual liver volume, in keeping with the observed hepatic AAA uptake. In patients with stable cirrhosis and a TIPSS, the plasma BCAA/AAA ratio was lower than in controls 0.19 +/- 0.09 vs. controls: 3.63 +/- 0.34). Gastrointestinal bleeding in cirrhotics with a TIPSS induced disturbances in BCAA levels and the BCAA/AAA ratio and induced catabolism, which could partly be corrected by isoleucine administration. AAA may be important in the pathogenesis of HE, but it is unlikely that they are the sole factors. HE most likely is a syndrome with multifactorial pathogenesis, where hyperammonemia, AAA/BCAA imbalances, inflammation, brain edema, and neurotransmitter changes interact. Novel therapies to normalize AAA levels in patients with liver failure (such as the molecular adsorbent recirculating system dialysis device) should probably be combined with supplementation of e.g. isoleucine and enhancing ammonia excretion by the kidneys.

Type:Article
Title:Aromatic amino acid metabolism during liver failure
Location:Vancouver, CANADA
Keywords:INSUFFICIENCY-INDUCED HYPERAMMONEMIA, CHRONIC RENAL-INSUFFICIENCY, CEREBRAL-CORTEX AMMONIA, ALBUMIN DIALYSIS MARS, BLOOD-BRAIN-BARRIER, ACUTE HEPATIC-COMA, GLUTAMINE-METABOLISM, PHENYLALANINE HYDROXYLATION, HEPATOCELLULAR-CARCINOMA, INTERORGAN AMMONIA

Archive Staff Only: edit this record